Abstract
ONE of the early events in the haemostatic process is the adherence of blood platelets to collagen of the subendothelium. Subsequent platelet-to-platelet adhesion then leads to the formation of a haemostatic plug. The role of a plasma factor in this process was recognised after the discovery1,2 that the prolonged bleeding time of patients with Von Willebrand disease could be corrected by transfusion of plasma or cryoprecipitate. This plasma factor, then named Von Willebrand factor, was later identified as factor VIII (anti-haemophilic factor A (ref. 3)). The current concept is that Von Willebrand factor and factor VIII are present in a complex, which can be dissociated in certain conditions. Despite this progress, little is yet known about the role of the factor VIII-Von Willebrand factor complex (factor VIII–VWF) in the haemostatic plug formation. Tschoppet al. showed that the Von Willebrand factor was required for normal adhesion of platelets to rabbit subendothelium in a perfusion chamber using blood from patients with Von Willebrand disease4. The role of factor VIII–VWF in platelet adhesion is also important for the development of atherosclerosis. In this process, adherence of platelets is followed by degranulation and concomitant secretion of factors causing intimai migration and proliferation of smooth muscle cells5,6. Defective adherence of platelets was shown to protect against experimental atherosclerosis7,8. We present here evidence that factor VIII–VWF binds to subendothelium of human arteries and that subendothelium-bound factor VIII–VWF mediates the platelet adhesion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nilsson, I. M., Blombäck, M. & Blombäck, B. Acta med. scand. 164, 263–278 (1959).
Cornu, P., Larrieu, M. J., Caen, J. & Bernard, J. Br. J. Haemat. 9, 189–202 (1963).
Bouma, B. N., Wiegerinck, Y., Sixma, J. J., Van Mourik, J. A. & Mochtar, I. A. Nature new Biol. 236, 104–106 (1972).
Tschopp, T. B., Weiss, H. J. & Baumgartner, H. R. J. Lab. clin. Med. 83, 296–300 (1974).
Stemerman, M. B. & Ross, R. J. exp. Med. 136, 769–789 (1972).
Ross, R., Glomset, J., Kariya, B. & Harker, L. A. Proc. natn. Acad. Sci. U.S.A. 71, 1207–1210 (1974).
Harker, L. A., Ross, R., Slichter, S. J. & Scott, C. R. J. clin. Invest. 58, 731–741 (1976).
Fuster, V. et al. J. clin. Invest. 61, 722–730 (1973).
Baumgartner, H. R. & Haudenschild, C. Ann. N.Y. Acad. Sci. 201, 22–36 (1972).
Abrahamsen, A. F. Scand. J. Haemat. 5, 53–63 (1968).
Evans, C., Packham, M. A. & Nishizawa, E. E. J. exp. Med. 128, 877–894 (1968).
Van Mourik, J. A. & Mochtar, I. A. Biochim. biophys. Acta 221, 677–679 (1970).
Over, J. et al. J. clin. Invest. 62, 223–234 (1978).
Wells, R. & Goldstone, J. in Rheology of Biological Systems (eds Gabelnick, H. L. & Litt, M.) 42 (Thomas, Springfield, 1973).
Baumgartner, H. R. Microvascular Res. 5, 167–179 (1973).
Lighthill, M. J. J. Fluid Mech. 52, 475–479 (1972).
Howard, M. A. & Firkin, B. G. Thromb. Diath. Haemorrhage 26, 362–369 (1971).
Jørgensen, L. & Borchgrevink, C. F. Acta path. microbiol. scand. 60, 55–82 (1964).
Hovig, T. & Stormorken, H. Acta path. microbiol. scand. Suppl. 248, 105–122 (1974).
Jaffe, E. A., Hoyer, L. W. & Nachman, R. L. Proc. natn. Acad. Sci. U.S.A. 71, 1906–1909 (1974).
Bloom, A. L., Giddings, J. C. & Wilks, J. C. Nature new Biol. 241, 217–219 (1973).
Holmberg, L., Mannucci, P. M., Turesson, L., Ruggeri, Z. M. & Nilsson, I. M. Scand. J. Haemat. 13, 33–38 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
SAKARIASSEN, K., BOLHUIS, P. & SIXMA, J. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII–Von Willebrand factor bound to the subendothelium. Nature 279, 636–638 (1979). https://doi.org/10.1038/279636a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/279636a0
This article is cited by
-
Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor
Gene Therapy (2023)
-
Neuroinflammation and neovascularization in diabetic eye diseases (DEDs): identification of potential pharmacotherapeutic targets
Molecular Biology Reports (2023)
-
Endothelial cells and coagulation
Cell and Tissue Research (2022)
-
Hemophilia A and B mice, but not VWF−/−mice, display bone defects in congenital development and remodeling after injury
Scientific Reports (2019)
-
Pre-procedural abnormal function of von Willebrand Factor is predictive of bleeding after surgical but not transcatheter aortic valve replacement
Journal of Thrombosis and Thrombolysis (2019)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.